I assume Avita one is class II resubmission with minimal effort fix it and it will get the approval in anytime from now, if shorts playing, that’s going to be a loose for them…
- Class I resubmissions: If the FDA determines that additional information or data from the sponsor can easily address minor deficiencies in their application, it is classified as a class 1 resubmission. Upon resubmission, the FDA has two to three months to review these applications.
- Class II resubmissions: If the FDA determines that significant changes or new data are needed to address sponsor deficiencies in their application, it is classified as a class 2 resubmission. Upon resubmission, the FDA has six months to review these applications.
Class I resubmissions: If the FDA determines that additional...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.53 |
Change
-0.130(4.89%) |
Mkt cap ! $157.6M | |||
| Open | High | Low | Value | Volume |
| $2.51 | $2.55 | $2.49 | $1.099M | 435.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 6453 | $2.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.53 | 10697 | 6 |
View Market Depth
| Last trade - 14.42pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.52 |
Change
-0.130 ( 3.93 %) |
||||
| Open | High | Low | Volume | ||
| $2.51 | $2.55 | $2.51 | 18325 | ||
| Last updated 14.42pm 24/05/2024 ? | |||||
| AVH (ASX) Chart |